NCT04963335 (ExergaMS) is a NA clinical trial of Exergame Training in Multiple Sclerosis, sponsored by Eling DeBruin.

Who is sponsoring NCT04963335?

NCT04963335 is sponsored by Eling DeBruin.

What drugs are being tested in NCT04963335?

Interventions in NCT04963335: Exergame Training.

What condition does NCT04963335 study?

NCT04963335 studies Multiple Sclerosis.

Is NCT04963335 still recruiting?

NCT04963335 is currently status unknown. Last updated 15 July 2021.

Last reviewed 2021-07-15 · How we verify

NCT04963335: ExergaMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMS

Status unknown NA Last updated 15 July 2021

What this trial tests

NA trial testing Exergame Training in Multiple Sclerosis in 30 participants. Status unknown.

Timeline

28 March 2021

Primary endpoint
31 July 2021

31 July 2021

Quick facts

Lead sponsor	Eling DeBruin
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	30
Start date	28 March 2021
Primary completion	31 July 2021
Estimated completion	31 July 2021
Sites	1 location across Switzerland

Drugs / interventions tested

Exergame Training

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Eling DeBruin

Who can join

Adults 30 to 85, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the feasibility and preliminary effects of user-centered exergames (video game-based physical exercise) in persons with multiple sclerosis (PwMS). The user-centered exergames were developed within a interdisciplinary team to meet the requirements of the end-users. The individualized exergames were designed for the Dividat Senso, a pressure sensitive plate connected to a personal computer and a frontal screen. This concurrent motor-cognitive training aims to improve motor and cognitive functions in an ecological valid setting. The cognitive functions are triggered by specific stimuli in the game scenarios. The video games are controlled via specific (whole body) movements as steps, weight shifting, jumps, and arm movements. The training focus is mainly on balance and coordination as well as executive functions and attention. Furthermore, the meaningful games (colorful and appealing visuals) were designed to motivate the players to move. Participants are allocated to the either the intervention group or the control group (quasi-randomization). Participants in the intervention group perform 16 training session over a period of 4 to 8 weeks (depending on in- or out-patient). One training session lasts between 15-25 minutes. Since the difficulty of the games is adaptive to the ability level of each participant, they should neither be over- nor under-challenged. Participates in the control group continue their normal daily routine over 8 weeks. Measurements are performed before, in-between, and after the intervention period to assess feasibility parameters as well as motor and cognitive functions in all participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exergame Training

Trials testing the same drug.

NCT05429255 — Aerobic Exercise in Patients With Stroke · NA · completed
NCT04296708 — ExerCube Training on Executive Functions in Young Athletes · NA · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Eling DeBruin trials

Trials by the same sponsor.

NCT05387057 — Effectiveness of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder · NA · completed
NCT04996654 — Feasibility of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder · NA · completed
NCT04872153 — Exergames in In-patient Rehabilitation · NA · completed
NCT03676452 — The Effects of an Exergame Training on Body and Brain of Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04963335 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eling DeBruin
Last refreshed: 15 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04963335.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing